Levothyroxine Sodium
NDC 42292-038, levothyroxine sodium, tablet, from Mylan Institutional Inc..
- Product NDC
- 42292-038
- Status
- Listed
- Labeler
- Mylan Institutional Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076187
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42292-038 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE SODIUM88 ug/1
Pharmacologic classes
Thyroxine [CS]; l-Thyroxine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42292-038-20 | 42292003820 | 100 BLISTER PACK in 1 CARTON (42292-038-20) / 1 TABLET in 1 BLISTER PACK (42292-038-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cd69c192-cd3f-47e6-b0a6-c536ffed5c4bNADAC price for package 42292003820
GET /v1/drugs/nadac/42292003820
Use it
Look up 42292-038 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42292-038 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42292-038. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.